Balloon catheter sinusotomy: One‐year follow‐up—Outcomes and role in functional endoscopic sinus surgery

Abstract

Balloon catheter sinusotomy results were durable over the study period, showing long-term effectiveness.

Efficacy & Outcomes of Balloon Sinuplasty in Chronic Rhinosinusitis: A Prospective Study

“…A prospective multicenter CLEAR (Clinical evaluation to confirm safety and efficacy of sinuplasty in the paranasal sinuses) study of 115 patients across 9 physician practices, highlighted an impressive safety profile (zero adverse events), durability of patency (98% patency of observed ostia after 6 months), and significant improvement in patient symptoms and quality of life [12]. Of the 20 patients in our study assessed by diagnostic nasal endoscopy at periodic intervals, 92% had widely patent ostia from their first review at 1 week postoperatively till the completion of 1 year of follow up.…”

“…Careful case evaluation & selection remains paramount in providing the best outcomes with this technique. Balloon Sinuplasty has tangible benefits such as a reduction in invasiveness of the intervention, hospital stay, recovery time, post-operative debridements, post-operative medications, and office follow-up visits [11][12][13].…”

Long-term follow-up after ESS and balloon sinuplasty: Comparison of symptom reduction and patient satisfaction

“…In our 2-year follow-up study we demonstrated that patient satisfaction and symptom reduction were equal in both groups. However, in number of acute exacerbations ESS seems to be superior to balloon sinuplasty [14].…”

The MicroFlow Spacer: A Drug-Eluting Stent for the Ethmoid Sinus

“…In September 2005, Balloon Sinuplasty TM (Acclarent, Inc.) was introduced as a minimally invasive option to widen sinus ostia and their transition spaces while preserving the corresponding mucosa. The outcome, efficacy, and safety of the balloon dilation technology as applied to the frontal, maxillary and sphenoid sinuses has been well vetted and reported [2][3][4][5][6][7][8][9]. However, due to the complex drainage patterns and interconnected nature of the ethmoid complex, the balloon technology was not initially suited to treat chronic ethmoid disease [10].…”